The chiral compounds (R)- and (S)-N-(p-tolylsulfonyl)benzenesulfonimidamide have been prepared efficiently from N-(p-tolylsulfonyl)benzenesulfonimidoyl chloride and both enantiomers were transformed into chiral selenium diimide reagents, (S)- and (R)-N,N′-bis[N-(p-tolylsulfonyl)benzenesulfonimidoyl]selenium diimide, respectively, for the asymmetric allylic amination of olefins. Asymmetric allylic amination of methylenecyclohexane with the S-configured selenium diimide reagent afforded allylic amide, (1S)-N-[(R)-N-(p-tolylsulfonyl)benzenesulfonimidoyl]-2-methylenecyclohexylamine as a major diastereomer (42% diastereomeric excess). Similarly, cyclohexene, 1-heptene, and cyclooctene gave chiral allylic amides with 34%, 32%, and 20% diastereomeric excess, respectively. It is apparent that the S-configured diimido selenium reagent gives S-configured allylic amides, and that the R-configured reagent affords R-configured allylic amides as the major diastereomers in all of the cases investigated.
No takes yet. Share an insight, caveat, or question.
Tsushima et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: